                         SEQUENCE LISTING

<110>  SUMO Biosciences Inc.
 
<120>  SUMO INHIBITOR COMPOUNDS AND USES THEREOF

<130>  33082/54041B

<150>  PCT/US2020/014105
<151>  2020-01-17

<150>  US 62/820,703
<151>  2019-03-19

<160>  6     

<170>  PatentIn version 3.5

<210>  1
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  1

Leu Val Gly Ala Gly Ala Ile Gly Cys Glu Leu Leu Lys 
1               5                   10              


<210>  2
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  2

Val Val Gly Ala Gly Gly Ile Gly Cys Glu Leu Leu Lys 
1               5                   10              


<210>  3
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  3

Val Ile Gly Ala Gly Gly Leu Gly Cys Glu Leu Leu Lys 
1               5                   10              


<210>  4
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  4

Ile Val Gly Cys Gly Gly Leu Gly Cys Pro Ala Gln 
1               5                   10          


<210>  5
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  5

Leu Val Gly Ala Gly Ala Ile Gly Cys Glu Leu Leu Lys 
1               5                   10              


<210>  6
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  6

Leu Leu Gly Ala Gly Thr Leu Gly Cys Asn Val Ala Arg 
1               5                   10              


